The Effect Of Flurbiprofen And Naproxen Sodium On Intra‐Uterine Pressure And Menstrual Pain In Patients With Primary Dysmenorrhea
article
OA: closed
CC0
⤵ 3 in-corpus citations
Abstract
The effects of flurbiprofen (100 mg) and naproxen sodium (500 mg) on intrauterine pressure and menstrual pain were assessed in 8 women with primary dysmenorrhea using a double-blind parallel study technique. Intrauterine pressure was recorded with a microtransducer catheter for 4 h and resting pressure, active pressure, frequency of pressure cycles, and the area under the curve were analysed in 30 min periods. Prior to medication all the patients displayed signs of uterine hyperactivity as judged by a high resting pressure 55.3 +/- 3.8 mm Hg, high active pressure 175.0 +/- 6.1 mm Hg and a high frequency of pressure cycles 12.3 +/- 0.7 contractions per 0.5 h. Oral administration of flurbiprofen and naproxen sodium significantly suppressed uterine activity and was associated with a significant reduction in pain intensity. However no significant differences were recorded between the two drugs regarding their effects on intrauterine pressure and pain intensity.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients 1977
- EFFECTS OF TERBUTALINE ON MYOMETRIAL ACTIVITY, UTERINE BLOOD FLOW, AND LOWER ABDOMINAL PAIN IN WOMEN WITH PRIMARY DYSMENORRHOEA 1976
- MYOMETRIAL PHYSIOLOGY AND ITS RELATION TO PELVIC PAIN 1947
- The role of prostaglandin synthetase inhibitors in gynaecology. 1981
Cited by (3)
- An Objective Evaluation of Flurbiprofen and Tranexamic Acid in the Treatment of Idiopathic Menorrhagia 1988
- Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea 2002
- Valdecoxib, a Cyclooxygenase-2-Specific Inhibitor, Is Effective in Treating Primary Dysmenorrhea 2002
References (16)
- EFFECTS OF TERBUTALINE ON MYOMETRIAL ACTIVITY, UTERINE BLOOD FLOW, AND LOWER ABDOMINAL PAIN IN WOMEN WITH PRIMARY DYSMENORRHOEA via openalex
- MYOMETRIAL PHYSIOLOGY AND ITS RELATION TO PELVIC PAIN via openalex
- The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients via openalex
- The role of prostaglandin synthetase inhibitors in gynaecology. via openalex
- W1996846584 via openalex
- W2024389975 via openalex
- W2039724533 via openalex
- W578373853 via openalex
- W2058906018 via openalex
- W2083717098 via openalex
- W2087172187 via openalex
- W2118569178 via openalex
- W2047228062 via openalex
- W1499479438 via openalex
- W1551258921 via openalex
- W1661158834 via openalex
Cited by (3)
- Valdecoxib, a Cyclooxygenase-2-Specific Inhibitor, Is Effective in Treating Primary Dysmenorrhea 2002
- Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea 2002
- An Objective Evaluation of Flurbiprofen and Tranexamic Acid in the Treatment of Idiopathic Menorrhagia 1988
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-05T02:00:03.366016+00:00
License: CC0
· commercial use OK